drugset
drugset / Trial / NCT04345770

Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in Locally Advanced Gastric Cancer

NCT04345770 ↗

Phase 2 Unknown 100 enrolled Wuhan University
RandomizedParallel-groupOpen-labelTreatment

Summary

The efficacy of HIPEC in prevention of local recurrence, distant metastasis or peritoneal metastasis in locally advanced gastric cancer is not definite. The hypothesis of the trial is that radical gastrectomy combined with HIPEC is superior to only radical gastrectomy in terms of overall survival.

Timeline

Start
2020-04-01
Primary completion
2025-03-31
Completion
2025-05-31

Drugs

EvaluationDrugModalityDoseRoute
Background Oxaliplatin Small molecule 130 mg/m2 —
Background Tegafur,Gimeracil and Oteracil Porassium Unknown 60 mg —

Indications

gastric cancer